Cataracts in neutrophil donors stimulated with adrenal corticosteroids

被引:31
作者
Ghodsi, Z
Strauss, RG
机构
[1] Univ Iowa, Coll Med, Dept Pathol, DeGowin Blood Ctr, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Med, Dept Pathol, DeGowin Blood Ctr, Iowa City, IA 52242 USA
[3] Univ Iowa, Coll Med, Dept Pediat, DeGowin Blood Ctr, Iowa City, IA 52242 USA
关键词
D O I
10.1046/j.1537-2995.2001.41121464.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: A relatively young man (43 years old) was found to have a cataract after receiving prednisone before each of 35 neutrophil (PMN) donations over several years. Because corticosteroids are known to induce posterior subcapsular cataracts (PSCs), additional repeat PMN donors were examined ophthalmologically. STUDY DESIGN AND METHODS: A controlled, blinded study was performed in 11 PMN donors who received prednisone with or without G-CSF before 17 to 46 leukapheresis donations over an average of 8.5 years. Control subjects were nine plateletpheresis donors of comparable age and donation experience, but they had never donated PMNs. A complete eye examination was performed by an ophthalmologist who was unaware of the donor's status (PMN vs. platelet). RESULTS: Mild PSCs were found in 36 percent (4/11) of PMN donors versus 0 of 9 platelet donors (p = 0.068). Five of the 22 PMN donor eyes involved versus 0 of the 18 platelet donor eyes involved exhibited PSCs (p = 0.040). Cortical and nuclear cataracts were found similarly in both groups of donors (82% PMN vs. 56% platelet donors; p = 0.217); this indicated that lifestyle factors, independent of corticosteroids, that might predispose to cataract formation probably were comparable. CONCLUSION: Corticosteroids given before PMN donations by leukapheresis might increase the risk of PSCs. Because of widespread renewed interest in PMN transfusions, this potential risk factor-if confirmed by studies of additional PMN donors-is of great international importance. Other centers are urged to perform ophthalmologic examinations on repeat PMN donors to clarify this issue.
引用
收藏
页码:1464 / 1468
页数:5
相关论文
共 27 条
[21]   EFFECTS OF INTENSIVE GRANULOCYTE DONATION ON DONORS AND YIELDS [J].
STRAUSS, RG ;
GOEKEN, JA ;
ECKERMANN, I ;
MCENTEGART, CM ;
HULSE, JD .
TRANSFUSION, 1986, 26 (05) :441-445
[22]  
STRAUSS RG, 2000, HEMATOLOGY BASIC PRI, P2257
[23]   Treatment of normal individuals with granulocyte-colony-stimulating factor: Donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells [J].
Stroncek, DF ;
Clay, ME ;
Petzoldt, ML ;
Smith, J ;
Jaszcz, W ;
Oldham, FB ;
McCullough, J .
TRANSFUSION, 1996, 36 (07) :601-610
[24]   Administration of G-CSF plus dexamethasone produces greater granulocyte concentrate yields while causing no more donor toxicity than G-CSF alone [J].
Stroncek, DF ;
Yau, YY ;
Oblitas, J ;
Leitman, SF .
TRANSFUSION, 2001, 41 (08) :1037-1044
[25]   ASSOCIATION OF OCULAR CATARACTS WITH INHALED AND ORAL STEROID-THERAPY DURING LONG-TERM TREATMENT OF ASTHMA [J].
TOOGOOD, JH ;
MARKOV, AE ;
BASKERVILLE, J ;
DYSON, C .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (02) :571-579
[26]   An international view of hydroxyethyl starches [J].
Treib, J ;
Baron, JF ;
Grauer, MT ;
Strauss, RG .
INTENSIVE CARE MEDICINE, 1999, 25 (03) :258-268
[27]  
Vamvakas EC, 1996, J CLIN APHERESIS, V11, P1